Literature DB >> 2012151

Initial glaucomatous optic disk and retinal nerve fiber layer abnormalities and their progression.

A Tuulonen1, P J Airaksinen.   

Abstract

We attempted to identify the initial glaucomatous changes of the optic disk and retinal nerve fiber layer and to analyze how these changes subsequently progressed. Of 61 eyes of 61 patients with ocular hypertension, 23 (38%) developed glaucoma during ten years of follow-up (range, five to 15 years). The initial sign of glaucomatous damage was diffuse enlargement of the optic disk cup in ten of 23 eyes or generalized thinning of the nerve fiber layer without localized changes in 12 of 23 eyes. We found localized optic disk damage in ten of 23 patients and localized retinal nerve fiber layer damage in 11 of 23 patients alone or in combination with diffuse damage. In 13 of 23 eyes, the cupping ended up in diffuse enlargement with even more profound thinning of the neural rim in the upper and lower temporal disk margins. There seems to be great variability in the appearance and progression of the initial glaucomatous optic disk and nerve fiber layer abnormalities in patients with increased intraocular pressure.

Entities:  

Mesh:

Year:  1991        PMID: 2012151     DOI: 10.1016/s0002-9394(14)72385-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  72 in total

1.  Variability across the optic nerve head in scanning laser tomography.

Authors:  J C H Tan; D F Garway-Heath; R A Hitchings
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

2.  Structure/function studies and the effects of memantine in monkeys with experimental glaucoma.

Authors:  B'ann T Gabelt; Carol A Rasmussen; Ozan Y Tektas; Charlene B Y Kim; John C Peterson; T Michael Nork; James N Ver Hoeve; Elke Lütjen-Drecoll; Paul L Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-30       Impact factor: 4.799

3.  Deformation of the early glaucomatous monkey optic nerve head connective tissue after acute IOP elevation in 3-D histomorphometric reconstructions.

Authors:  Hongli Yang; Hilary Thompson; Michael D Roberts; Ian A Sigal; J Crawford Downs; Claude F Burgoyne
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

4.  Functional involvement of cone photoreceptors in advanced glaucoma: a multifocal electroretinogram study.

Authors:  Ajoy Vincent; Rohit Shetty; Sathi A V Devi; Mathew K Kurian; Ramgopal Balu; Bhujang Shetty
Journal:  Doc Ophthalmol       Date:  2010-03-25       Impact factor: 2.379

5.  Optic disc imaging in perimetrically normal eyes of glaucoma patients with unilateral field loss.

Authors:  Joseph Caprioli; Kouros Nouri-Mahdavi; Simon K Law; Federico Badalà
Journal:  Trans Am Ophthalmol Soc       Date:  2006

6.  Symmetry between the right and left eyes of the normal retinal nerve fiber layer measured with optical coherence tomography (an AOS thesis).

Authors:  Donald L Budenz
Journal:  Trans Am Ophthalmol Soc       Date:  2008

7.  Discrepancy between optic disc and nerve fiber layer assessment and optical coherence tomography in detecting glaucomatous progression.

Authors:  Jong Rak Lee; Kyung Rim Sung; Jung Hwa Na; Kilhwan Shon; Kyoung Sub Lee
Journal:  Jpn J Ophthalmol       Date:  2013-10-05       Impact factor: 2.447

8.  Integrins in the optic nerve head: potential roles in glaucomatous optic neuropathy (an American Ophthalmological Society thesis).

Authors:  John C Morrison
Journal:  Trans Am Ophthalmol Soc       Date:  2006

9.  Comparison of Spectralis-OCT, GDxVCC and GDxECC in assessing retinal nerve fiber layer (RNFL) in glaucomatous patients.

Authors:  Maurice Schallenberg; Dirk Dekowski; Stephan Kremmer; J Michael Selbach; Klaus-Peter Steuhl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-19       Impact factor: 3.117

10.  Localised wedge shaped defects of the retinal nerve fibre layer in glaucoma.

Authors:  J B Jonas; D Schiro
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.